Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 79Squamous Cell Carcinoma of Head and Neck 44Lung Neoplasms 35Urinary Bladder Neoplasms 22Oropharyngeal Neoplasms 22Nasopharyngeal Carcinoma 18Head and Neck Neoplasms 18Parkinson Disease 4, Autosomal Dominant Lewy Body 15Carcinoma 15Biliary Tract Neoplasms 15Small Cell Lung Carcinoma 14Esophageal Squamous Cell Carcinoma 14Uterine Cervical Neoplasms 13Neoplasm Metastasis 13Cholangiocarcinoma 13Neoplasms 12Colorectal Neoplasms 12Pancreatic Neoplasms 11Ovarian Neoplasms 11Carcinoma, Squamous Cell 11Laryngeal Neoplasms 10Stomach Neoplasms 9Mouth Neoplasms 9Endometrial Neoplasms 9Gallbladder Neoplasms 8Carcinoma, Transitional Cell 8Hypopharyngeal Neoplasms 7Esophageal Neoplasms 7Triple Negative Breast Neoplasms 6Mesothelioma, Malignant 6

Interventions

pegfilgrastim 1Gemcitabine 1Cystectomy 1Cisplatin 1Chemoradiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Infiltrating Bladder Urothelial Carcinoma × Cisplatin × 90 days × Clear all
NCT03609216 2026-04-13

Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations

Alliance for Clinical Trials in Oncology

Phase 2 Active not recruiting
237 enrolled
Genitourinary

Infiltrating Bladder Urothelial Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡